Glycine transport in both normal and nonketotic hyperglycinemia fibroblasts was shown to occur by a sodium-dependent system. No significant difference could be detected in either the Km's (1.4 to 2.0 mM) or the Vm,' s (6.2 to 16 nmole per mg protein per min) of the three control and three patient cell lines. Valine was a weak competitive inhibitor of glycine uptake. Ki's from both groups fell into the 5.6 to 5.8 mM range. Plasma levels of valine of one patient reached a maximum of 0.6 mM following a valine load. Glycine cleavage activity could not be detected in either control or nonketotichypergl~cinemia fibroblast lines. Serine utilization was the same in both nonketotic hyperglycinemia and control lines.
Summary
Glycine transport in both normal and nonketotic hyperglycinemia fibroblasts was shown to occur by a sodium-dependent system. No significant difference could be detected in either the Km's (1.4 to 2.0 mM) or the Vm,' s (6.2 to 16 nmole per mg protein per min) of the three control and three patient cell lines. Valine was a weak competitive inhibitor of glycine uptake. Ki's from both groups fell into the 5.6 to 5.8 mM range. Plasma levels of valine of one patient reached a maximum of 0.6 mM following a valine load. Glycine cleavage activity could not be detected in either control or nonketotichypergl~cinemia fibroblast lines. Serine utilization was the same in both nonketotic hyperglycinemia and control lines.
Speculation
The fibroblast lines of nonketotic hyperglycinemia patients used in our study indicate that a glycine transport defect is not the cause of the elevated cerebrospinal fluid glycine levels observed in nonketotic hyperglycinemia. The clinical valine effect is unlikely to be related to the inhibition of glycine transport by valine.
Nonketotic hyperglycinemia (NKH) is a metabolic disease characterized by the early onset of hypotonia, lethargy, and myoclonic convulsions. No treatment yet devised has avoided the profound mental retardation in surviving patients. A disproportionate elevation of glycine is seen in the cerebrospinal fluid and a decrease in the activity of the glycine cleavage enzyme in brain and liver (10. 12) has been reported. However. this abnormality has also been found in the biochemically distinct disorder, ketotic hyperglycinemia (2, 12) which raises the possibility that it may not be the primary genetic defect in NKH.
In some patients with NKH, valine has been shown to induce coma and markedly exacerbate the hypotonia (7. 8) . This striking effect has led to the suggestion that NKH represents a defect in valine metabolism (8) .
More recently. Revsin and Morrow ( I 1 ) found V, . , differences in fibroblast glycine transport between NKH and control cell lines. An inhibition of glycine transport by valine was briefly noted by these authors.
In our study, we investigated the influence of valine on glycine transport as a possible cause of the clinical valine effect. Glycine oxidation and serine utilization in fibroblasts were also examined.
MATERIALS AND METHODS
Human diploid fibroblasts (24) from three normal and three NKH patients were grown in Eagle's minimal essential medium (13) containing 10% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 pg/ml).
For transport studies, cells were grown on washed sterile coverslips ( 1 l x 22 mm) (14) . With the fibroblasts at confluency, the 93 coverslips were rinsed twice with phosphate-buffered saline glucose (PBSG) [I30 mM NaCI, 5 mM KCI, 1.2 mM MgS04, 1 mM CaC12, 5 mM glucose. and 10 mM Na2HP04 (pH 7.4)]. In a final wash, the coverslips were left for one hr in PBSG at 37OC to minimize endogenous glycine levels.
The incubation procedure was similar to that of Foster and Pardee (3). Four yl of [2-L4C] glycine (15) were added per ml of incubation medium containing PBSG, unlabeled glycine, and, in some studies, valine. Incubations were camed out for 2 min at 37°C. After incubation, coverslips were rinsed in three separate solutions of PBSG (total rinse time, approximately 5 sec). Drained coverslips were then placed in a scintillation cocktail, TEG (16) , and left for one hr before counting. Protein was determined by a modification of the method of Lowry er al. (9) .
For studies of the metabolism of glycine and serine, fibroblasts were grown in Falcon flasks (17) , under the same conditions as the cells grown for transport studies. At confluency, cells were harvested with 0.25% trypsin and washed three times in isotonic saline. After the final spin (1000 rpm; Sorval RC-3) cells from each flask were resuspended in 1 ml of PBSG and disrupted by sonic vibration (18) . An incubation medium was prepared containing 1.5 mM NAD+, 1 mM dithiothreitol, 0.5 mM pyridoxal phosphate, and 1% (w/v) bovine serum albumin made up with PBSG (19) . Ten pl of either [l-14C]glycine (54 mCi/mole) (20) or DL-[l-'4C]serine (51 mCl/molt) (20) were added to 4 ml of the incubation medium. To a series of tubes each containing 2 p1 of I mM tetrahydrofolic acid in 0.2 mM mercaptoethanol, 0.1 ml of disrupted fibroblasts (0.2 to 0.5 mg protein) and 0.2 ml of incubation medium were added. Kontes center wells (21) containing 0.3 ml of soluene (22) were suspended from rubber caps that sealed the incubation tubes. Incubations were camed out at 37OC with gentle shaking for one hr. Tubes were then placed on ice, and the contents of each well was counted in Toluene-Liquifluor (23).
RESULTS

TRANSPORT STUDIES
The time course uptake of I and 2 mM glycine was linear for at least 20 min (Fig. 1) . The use of [2-14C] glycine in this study precluded the possibility of label loss by glycine oxidation subsequent to transport. No signficant difference in uptake pattern could be observed between NKH and control cell lines. Uptake in the absence of sodium or in the present of 10-% oubain was minimal and presumably reflects entrance of glycine by simple diffusion (Fig. 1 ). V, . . ' s for NKH cell lines were 6.2 to 16.6 nmoles per mg protein per min, and for controls, they were 6.0 to 10.0 nmoles per mg protein per min. Corresponding K,' s were 1.4 to 2.0 mM and 1.6 to 2.0 mM (Fig. 2) . Valine was a weak competitive inhibitor of both NKH and control cell lines with Ki's for both groups in the 5.6 to 5.8 mM range (Table 1; Figs. 3 and 4) . 5.7
5.4
GLYClNE METABOLISM
I n the incubation studies using labeled glycine, n o distinction could b e made between nonenzymatic I4CO2 production a n d that formed in the presence o f either disrupted o r whole fibroblasts.
COP release did not significantly lower the pH of the incubation medium. T h e removal of each component, in turn, from the incubation medium did not alter this result a n d increasing the incubation time u p to 6 h r was without effect. Glycine oxidation 
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in fibroblasts was not detected by this method. A total of 48 incubations were carried out in this study.
SERINE METABOLISM
Similar incubation studies with ~~-[ l -'~C ] s e r i n e produced a different result. In this instance, the I4CO2 released in the presence of disrupted cells was only 50 to 60% of that observed in controls showing nonenzymatic C 0 2 production. This reduction in I4CO2 release was the same for both NKH and control cell lines. This result was obtained eight times.
DISCUSSION
The K,' s for glycine transport in the controls and NKH cell lines for laboratory (1.4 to 2.0 mM) are comparable with those obtained elsewhere (1.1 to 2.4 and 0.65 to 4.2 mM) (5, 12 (12) because the latter authors used 20-min incubation times while the former incubated for only one min. However. this point is equivocal because the rate is the same for at least 20 min if the uptake is linear as it was in this study.
The pathogenesis of the coma following valine loading is unknown. It appeared possible that this amino acid inhibits glycine transport in NKH more than in controls. However, there was no significant difference in the Ki's for valine inhibition of glycine transport in fibroblasts. Plasma valine levels in the valine loaded NKH patient did not exceed 0.6 mM (Fig. 5) , which is less than one-eight of the concentration required to effect a half saturation of the glycine transport system. Assuming that the findings in fibroblasts reflect transport in the central nervous system, these data do not suggest that the clinical valine effect is related to inhibition of glycine transport by valine.
Demonstration A much greater I4CO2 release was reported when cells were grown in F10 medium rather than Eagle's medium which has a higher isoleucine content (4) . In more recent studies Kolvraa (6) could not observe a significant I4CO2 release from fibroblasts grown on either F10 or Eagle's medium. We also could not show any I4CO2 release from the fibroblasts in our studies. The reduction of ''Con release from DL-[I-"Clserine in the presence of cell sonicates presumably represents the ultization of L-serine by pathways that do not immediately release COa. The reduction was the same in both NKH and control lines and indicates that there is probably no defect in pathways of serine metabolism in this disease.
